Protagonist Therapeutics ... (PTGX)
NASDAQ: PTGX
· Real-Time Price · USD
56.04
1.05 (1.91%)
At close: Aug 15, 2025, 3:59 PM
56.07
0.05%
After-hours: Aug 15, 2025, 04:34 PM EDT
Protagonist Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 203.63M | 207.8M | 434.43M | 323.8M | 319.12M | 314.95M | 60M | n/a | n/a | 859K | 26.58M | 35.2M | 45.48M | 46.89M | 27.36M | 24.39M | 27.22M | 31.17M |
Cost of Revenue | n/a | 892K | 1.71M | 2.54M | 3.37M | 3.3M | 3.31M | 2.74M | 2.76M | 2.78M | 2.79M | 3.35M | 2.5M | 1.65M | 819K | n/a | n/a | n/a |
Gross Profit | 203.03M | 206.31M | 432.12M | 321.25M | 315.75M | 311.65M | 56.69M | -2.74M | -2.76M | -1.93M | 23.8M | 31.85M | 42.99M | 45.24M | 26.54M | 24.39M | 27.22M | 31.17M |
Operating Income | 23.98M | 27.22M | 252.84M | 149.11M | 152.24M | 148.68M | -93.65M | -153.22M | -147.19M | -146.28M | -131.37M | -131.87M | -133.5M | -122.94M | -125.84M | -107.66M | -81.5M | -68.84M |
Interest Income | 29.51M | 29.51M | 26.32M | 23.7M | 20.27M | 16.78M | 14.9M | 12.91M | 9.81M | 6.38M | 4.06M | 1.93M | 896K | 509K | 443K | 401K | 366K | 476K |
Pretax Income | 53.78M | 57.09M | 279.41M | 173.08M | 172.6M | 165.44M | -78.95M | -140.48M | -137.61M | -140.19M | -127.39M | -130.11M | -132.68M | -122.48M | -125.55M | -107.53M | -81.49M | -68.94M |
Net Income | 52.04M | 56.19M | 275.19M | 170.85M | 169.95M | 162.11M | -76.66M | -135.28M | -131.34M | -133.51M | -122.83M | -128.45M | -132.09M | -122.3M | -125.55M | -107.53M | -81.49M | -70.07M |
Selling & General & Admin | 41.4M | 39.4M | 41.75M | 40.85M | 38.35M | 38.98M | 33.49M | 32.07M | 31.31M | 29.83M | 31.74M | 32.37M | 32.72M | 31.75M | 27.2M | 24.93M | 22.57M | 20.03M |
Research & Development | 143.8M | 140.29M | 138.13M | 132.12M | 126.82M | 126.48M | 120.16M | 121.15M | 115.88M | 117.31M | 126.22M | 134.7M | 146.26M | 138.08M | 126.01M | 107.12M | 86.16M | 79.98M |
Other Expenses | n/a | 97K | 78K | 122K | 91K | -25K | -201K | -174K | -229K | -288K | -80K | -164K | -78K | -57K | -149K | -145K | -204K | -147K |
Operating Expenses | 185.2M | 179.69M | 179.88M | 172.97M | 165.17M | 165.46M | 153.65M | 153.22M | 147.19M | 147.14M | 157.95M | 167.07M | 178.98M | 169.82M | 153.2M | 132.05M | 108.72M | 100.01M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 127K | 146K | 355K |
Selling & Marketing Expenses | n/a | -892K | -1.71M | -1.71M | -1.71M | -820K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 137.62M | 180.58M | 181.59M | 174.68M | 166.88M | 166.28M | 153.65M | 153.22M | 147.19M | 147.14M | 157.95M | 167.07M | 178.98M | 169.82M | 153.2M | 132.05M | 108.72M | 100.01M |
Income Tax Expense | 1.74M | 894K | 4.22M | 2.23M | 2.65M | 3.33M | -2.3M | -5.21M | -6.28M | -6.68M | -4.57M | -1.66M | -465K | -116K | -14K | -14K | -176K | 1.01M |
Shares Outstanding (Basic) | 63.51M | 62.96M | 62.33M | 61.77M | 61.31M | 60.86M | 60.39M | 59.18M | 56.78M | 50.57M | 49.26M | 48.8M | 48.85M | 48.67M | 48.15M | 47.99M | 44.86M | 44.22M |
Shares Outstanding (Diluted) | 63.51M | 62.96M | 66.41M | 61.77M | 61.31M | 63.6M | 61.8M | 59.18M | 56.78M | 50.57M | 49.26M | 49.11M | 49.05M | 48.75M | 48.15M | 47.99M | 44.86M | 44.22M |
EPS (Basic) | 0.83 | 0.88 | 4.48 | 2.82 | 2.78 | 2.60 | -1.43 | -2.52 | -2.56 | -2.71 | -2.52 | -2.65 | -2.73 | -2.59 | -2.7 | -2.41 | -1.92 | -1.82 |
EPS (Diluted) | 0.70 | 0.75 | 4.20 | 2.66 | 2.62 | 2.44 | -1.44 | -2.52 | -2.55 | -2.7 | -2.51 | -2.64 | -2.73 | -2.59 | -2.7 | -2.41 | -1.92 | -1.82 |
EBITDA | 25.4M | 28.65M | 254.85M | 151.41M | 153.89M | 150.33M | -91.99M | -149.81M | -142.93M | -140.77M | -125.68M | -128.73M | -130.5M | -120.56M | -123.86M | -105.44M | -79.64M | -66.92M |
EBIT | 23.98M | 27.22M | 252.84M | 149.11M | 152.24M | 148.68M | -93.65M | -150.9M | -144.87M | -143.96M | -129.05M | -131.76M | -133.39M | -122.83M | -125.74M | -107.59M | -81.43M | -68.64M |
Depreciation & Amortization | 1.42M | 2.31M | 2.9M | 3.19M | 3.37M | 3.3M | 3.31M | 2.74M | 2.76M | 2.78M | 2.79M | 3.35M | 3.2M | 2.98M | 2.77M | 2.59M | 2.51M | 2.53M |